JACE® is comprised of autologous cultured epidermis produced by culturing isolated keratinocytes derived from the skin of patients. Sheets of epidermis are produced for the treatment of scars, vitiligo, nevi (birthmarks), ulcers, skin-graft donor sites, severe burns and other disorders.
In patients with skin injuries, epithelial cells began to form colonies within 3 days of implantation. The cultured allografts were not detectable 1 month after implantation and were integrated to the skin, demonstrating that regeneration was induced.
Links related to the product - may include a range of information sources (e.g., press releases, websites, patents) related to the specific cell therapy application.
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access